Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
JNJ-2113 by Johnson & Johnson for Ulcerative Colitis: Likelihood of Approval
JNJ-2113 is under clinical development by Johnson & Johnson and currently in Phase II for Ulcerative Colitis. According to GlobalData,...
JNJ-2113 by Johnson & Johnson for Plaque Psoriasis (Psoriasis Vulgaris): Likelihood of Approval
JNJ-2113 is under clinical development by Johnson & Johnson and currently in Phase III for Plaque Psoriasis (Psoriasis Vulgaris). According...
JNJ-2113 by Johnson & Johnson for Psoriatic Arthritis: Likelihood of Approval
JNJ-2113 is under clinical development by Johnson & Johnson and currently in Phase III for Psoriatic Arthritis. According to GlobalData,...